Genomtec S.A. Financial Flexibility Index

Latest as of March 2026: -0.30x

Genomtec S.A. financial flexibility index. Genomtec S.A. (GMT) has a Financial Flexibility Index of -0.30x as of March 2026. Free cash flow of zł-1.81 Million (operating CF zł-1.84 Million minus capex zł27.00K) represents 0% of total liabilities (zł6.01 Million). See Genomtec S.A. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

-0.30x
Free Cash Flow / Total Liabilities

Free Cash Flow

zł-1.81 Million
Operating CF − Capex

Total Liabilities

zł6.01 Million
PLN

Capital Expenditures

zł27.00K
PLN

Financial Flexibility Index of Genomtec S.A. (2019–2024)

Financial flexibility index of Genomtec S.A. from 2019 to 2024. Historical Financial Flexibility Index trend for Genomtec S.A. across 6 annual periods. Explore debt repayment capacity of Genomtec S.A. to assess how comfortably operating cash covers total debt obligations.

Genomtec S.A. Financial Flexibility Index by Year (2019–2024)

Genomtec S.A. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Genomtec S.A.. For the full cash flow conversion analysis, see GMT operating cash flow.

Year Flexibility Index Free Cash Flow (PLN) Operating CF Total Liabilities YoY Change
2024 -0.71x zł-6.66 Million zł-6.72 Million zł9.44 Million ▼ -22.2%
2023 -0.58x zł-4.42 Million zł-7.95 Million zł7.67 Million ▼ -825.7%
2022 0.08x zł546.00K zł-3.79 Million zł6.87 Million ▲ +105.2%
2021 -1.53x zł-5.32 Million zł-5.53 Million zł3.48 Million ▼ -15.1%
2020 -1.33x zł-2.39 Million zł-2.52 Million zł1.80 Million ▼ -98.7%
2019 -0.67x zł-1.20 Million zł-1.69 Million zł1.80 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities